News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on PYC Therapeutics.
RELATED STOCKHEAD STORIES
Health & Biotech
ASX Health Winners: Biotechs up 10pc in November, and Janus Henderson’s prediction for 2024
Health & Biotech
ASX Health Stocks: 4DX skyrockets 54pc after US update on its XV LVAS scanning device
Health & Biotech
ASX Health Stocks: PYC on the same page with FDA, Cleo’s cancer test peer-reviewed
News
Market Highlights: Wall Street skids ahead of CPI; Wegovy could be ‘top selling drug in history’
Health & Biotech
ASX Health Stocks: PYC granted FDA Fast Track; BCAL announces breakthrough results
Health & Biotech
ASX Health Stocks: Successful toxicology tests pave the way for PYC’s Phase 2 clinical trial
News
CLOSING BELL: The ASX dips while we ‘hurry up and wait’ to see what The Budget holds
Health & Biotech
ASX Health Stocks: CardieX jumps 16pc after FDA clearance; 3 other ASX biotechs to commence trials
Health & Biotech
ASX Health Stocks: PYC to take second asset to clinical trial; FDA sees no issues in Botanix submission
Health & Biotech
ASX Health Stocks: Rhythm crashes 45pc after withdrawing TGA application for ColoSTAT
Health & Biotech
Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger
Health & Biotech
ASX Health Stocks: Sonic snaps up stake in Microba, sending MAP share price 60pc higher
Health & Biotech
ASX Biotech Stocks: Medibank says nope to paying ransom for data theft
Health & Biotech
ASX Health Stocks: Race to develop RNA-based therapies is well and truly on, as these two biotechs add new programs
News
Market Highlights: Dow Jones officially in bear market and 5 ASX small caps to watch on Tuesday
Health & Biotech
Check Up: Anteotech riding high with $1.9m refund, and Avecho inks supply agreement for CBD arthritis treatment
Health & Biotech